Shandong Sanyuan Biotechnology Co.,Ltd. (301206.SZ)

CNY 27.37

(-1.55%)

EBITDA Summary of Shandong Sanyuan Biotechnology Co.,Ltd.

  • Shandong Sanyuan Biotechnology Co.,Ltd.'s latest annual EBITDA in 2023 was 1.59 Million CNY , down -99.92% from previous year.
  • Shandong Sanyuan Biotechnology Co.,Ltd.'s latest quarterly EBITDA in 2024 Q3 was 29.91 Million CNY , down -76.16% from previous quarter.
  • Shandong Sanyuan Biotechnology Co.,Ltd. reported an annual EBITDA of 69.32 Million CNY in 2022, down -66.08% from previous year.
  • Shandong Sanyuan Biotechnology Co.,Ltd. reported an annual EBITDA of 641.9 Million CNY in 2021, up 115.53% from previous year.
  • Shandong Sanyuan Biotechnology Co.,Ltd. reported a quarterly EBITDA of 29.91 Million CNY for 2024 Q3, down -76.16% from previous quarter.
  • Shandong Sanyuan Biotechnology Co.,Ltd. reported a quarterly EBITDA of -5.49 Million CNY for 2024 Q1, down -270.25% from previous quarter.

Annual EBITDA Chart of Shandong Sanyuan Biotechnology Co.,Ltd. (2023 - 2013)

Historical Annual EBITDA of Shandong Sanyuan Biotechnology Co.,Ltd. (2023 - 2013)

Year EBITDA EBITDA Growth
2023 1.59 Million CNY -99.92%
2022 69.32 Million CNY -66.08%
2021 641.9 Million CNY 115.53%
2020 287.41 Million CNY 50.72%
2019 182 Million CNY 135.79%
2018 84.76 Million CNY 234.84%
2017 24.98 Million CNY 62.9%
2016 15.46 Million CNY 349.68%
2015 3.43 Million CNY 40.19%
2014 2.48 Million CNY 32.38%
2013 1.8 Million CNY 0.0%

Peer EBITDA Comparison of Shandong Sanyuan Biotechnology Co.,Ltd.

Name EBITDA EBITDA Difference
Guangxi Yuegui Guangye Holdings Co., Ltd. 305.38 Million CNY 99.478%
Nanning Sugar Industry Co.,Ltd. 349.43 Million CNY 99.544%